Track the 삼천당제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼천당제약 has recorded 5 insider filings. The latest transaction was reported on 10 July 2023 (Purchase). Among the most active insiders: 윤대인. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samchundang Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XKRX.